Amgen, an American multinational biopharmaceutical company headquartered in Thousand Oaks, California, and one of the world’s largest independent biotechnology companies, announced plans to open a new technology and innovation site in Hyderabad, Telangana.
Chief Minister A. Revanth Reddy and Industries Minister Duddilla Sridhar Babu met Dr. David Reese and Mr. Som Chattopadhyay at Amgen’s R&D site in San Francisco on Friday (August 09, 2024) to reaffirm their commitment to choose Hyderabad to open their next innovation site.
Speaking after the meeting, IT and Industries Minister Sridhar Babu said he was thrilled to note that Amgen had chosen Hyderabad to establish Amgen India. This development is a powerful endorsement of the world-class life sciences ecosystem being cultivated in Telangana.
Hyderabad was selected for its world-class talent across medicine, life sciences and data sciences and the rapidly advancing field of Artificial Intelligence (AI). The site can accommodate up to 3,000 people and will be operational in Q4 2024, a note from the CMO officials said. The site will offer roles that strengthen key areas of Amgen’s business, including AI, data science, life science and other additional global capabilities over time.
To lead Amgen’s expanded presence in India, Som Chattopadhyay has been appointed national executive for India. Amgen has nearly 27,000 employees and has a presence in approximately 100 countries and regions worldwide.
Today, Amgen is the world’s largest pure play medical biotechnology company, generating 28.2 billion U.S. dollars of revenue and employing over 26 thousand people worldwide.
